Expert Group Consensus From The Arabian Peninsula On The Diagnosis Of Late Onset Pompe Disease for orthopedists
![](/.imaging/webp/sanofi-templates/article-hero-w768/dam/campus-sanofi-bh/campus-sanofi-bh-new/science/Hero/science-hero.png/jcr:content/science%20hero.png)
Objective and Method
![](/dam/jcr:71cad275-cf3c-4c9a-8bce-4c1a5035f0f4/Asset%204@4x-100.png)
Consensus based on literature supporting clinical presentation and recommendations
Literature Analysis on LOPD Symptoms (Orthopedics): Hierarchy of Evidence
![](/dam/jcr:b172521c-2539-4086-8c46-38da1cbb1dff/Asset%206@4x.png)
Orthopedics-Specific
Clinical Presentation for Pediatric/Juvenile* LOPD Proposed During the First Meeting
![](/dam/jcr:5c66aa72-f11d-4d97-bd6b-9922b56bbbe5/bh.jpg)
Orthopedics-Specific
Clinical Presentation for Pediatric/Juvenile* LOPD Proposed During the First Meeting
![](/dam/jcr:55a807a6-a185-4708-8da9-1356f8a9a62b/Asset%209@4x.png)
Conclusion
![](/.imaging/webp/sanofi-templates/w1080/dam/campus-sanofi-bh/campus-sanofi-bh-new/science/Images/Asset-7-2x.png/jcr:content/Asset%207@2x.png)
Recommendation
Testing for Pompe disease must be done if any one specialty-specific symptom plus elevated CK/LDH/ALT/AST or a family history of unexplained muscle weakness is present.
*The age of patients with pediatric/juvenile LOPD ranges from 1 to 17 years.
Abbreviations
ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; CK: Creatine kinase; DBS: Dried blood spot testing; KSA: Kingdom of Saudi Arabia; LDH: Lactate dehydrogenase; LGMW: Limb–girdle muscle weakness; LOPD: Late-onset Pompe disease; UAE: United Arab Emirates.
References
- Al Shehri A, Al-Asmi A, Al Salti AM, et al. A multidisciplinary perspective addressing the diagnostic challenges of late-onset Pompe disease in the Arabian Peninsula region developed from an Expert Group Meeting. J Neuromuscul Dis. 2022;9(5):661–673.